Thierry Guillaume

4.4k total citations
179 papers, 2.7k citations indexed

About

Thierry Guillaume is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Thierry Guillaume has authored 179 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Hematology, 72 papers in Oncology and 52 papers in Immunology. Recurrent topics in Thierry Guillaume's work include Hematopoietic Stem Cell Transplantation (92 papers), Acute Myeloid Leukemia Research (35 papers) and Immune Cell Function and Interaction (25 papers). Thierry Guillaume is often cited by papers focused on Hematopoietic Stem Cell Transplantation (92 papers), Acute Myeloid Leukemia Research (35 papers) and Immune Cell Function and Interaction (25 papers). Thierry Guillaume collaborates with scholars based in France, Belgium and United States. Thierry Guillaume's co-authors include Michel Symann, Daniel B. Rubinstein, Patrice Chevallier, Philippe Moreau, Mohamad Mohty, Pierre Péterlin, Florent Malard, Alice Garnier, Viviane Dubruille and Beatrice Mahé and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Thierry Guillaume

172 papers receiving 2.6k citations

Peers

Countries citing papers authored by Thierry Guillaume

Since Specialization

Citations

This map shows the geographic impact of Thierry Guillaume's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Guillaume with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Guillaume more than expected).

Fields of papers citing papers by Thierry Guillaume

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Guillaume. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Guillaume. The network helps show where Thierry Guillaume may publish in the future.

Co-authorship network of co-authors of Thierry Guillaume

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Guillaume. A scholar is included among the top collaborators of Thierry Guillaume based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Guillaume. Thierry Guillaume is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial 2024 ·Blood Cancer Journal ·Éolia Brissot, Myriam Labopin, Hélène Labussière, Gaëlle Fossard, Patrice Chevallier, Thierry Guillaume, Ibrahim Yakoub‐Agha, Micha Srour, Claude‐Eric Bulabois, Anne Huynh, Sylvain Chantepie, Anne‐Lise Ménard, Marie‐Thérèse Rubio, Patrice Céballos, Rémy Duléry, Sabine Fürst, Florent Malard, Didier Blaise, Mohamad Mohty	12
2	Tocilizumab in combination with a standard induction chemotherapy in acute myeloid leukaemia patients (TOCILAM study): a single-centre, single-arm, phase 1 trial 2023 ·EClinicalMedicine ·Pierre Péterlin, Alice Garnier, Amandine Le Bourgeois, Thierry Guillaume, Yannick Le Bris, Olivier Theisen, Marie C. Béné, Marion Eveillard, Marie Rimbert, (unknown), Lucie Planche, Joëlle Gaschet, Patrice Chevallier	5
3	Complications stomatologiques dans le contexte de l’allogreffe de cellules hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) 2020 ·Bulletin du Cancer ·Laëtitia Souchet, Imran Ahmad, (unknown), Patrice Céballos, (unknown), (unknown), Pascal Turlure, Alban Villate, Émmanuelle Vigarios, Cécile Borel, Ibrahim Yakoub‐Agha, Thierry Guillaume	1
4	Injections de lymphocytes du donneur (DLI) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) 2018 ·Bulletin du Cancer ·John De Vos, Étienne Baudoux, Jacques‐Olivier Bay, Boris Calmels, Audrey Cras, Jean El Cheikh, (unknown), (unknown), Sylvain Lamure, (unknown), Anne‐Lise Ménard, Étienne Daguindau, Xavier Poiré, Ibrahim Yakoub‐Agha, Thierry Guillaume	11
5	Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients 2018 ·Biology of Blood and Marrow Transplantation ·(unknown), Caroline Bodet‐Milin, Clément Bailly, Thierry Guillaume, Pierre Péterlin, Alice Garnier, Amandine Le Bourgeois, Beatrice Mahé, Viviane Dubruille, Nicolas Blin, Cyrille Touzeau, Thomas Gastinne, Anne Lok, (unknown), Marie C. Béné, Steven Le Gouill, Philippe Moreau, Françoise Kraeber‐Bodéré, Patrice Chevallier	3
6	Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/−R) is an effective treatment with low toxicity in Hodgkin’s and non-Hodgkin’s lymphomas 2017 ·Annals of Hematology ·Benoît Tessoulin, (unknown), (unknown), (unknown), Thomas Gastinne, Philippe Moreau, Céline Bossard, Beatrice Mahé, Nicolas Blin, Viviane Dubruille, Cyrille Touzeau, (unknown), F. Perrin, Anne Lok, Thierry Guillaume, Alice Garnier, Pierre Péterlin, (unknown), Patrice Chevallier, Steven Le Gouill	9
7	Complete Donor T Cell Chimerism Predicts Lower Relapse Incidence after Standard Double Umbilical Cord Blood Reduced-Intensity Conditioning Regimen Allogeneic Transplantation in Adults 2014 ·Biology of Blood and Marrow Transplantation ·Pierre Péterlin, Jacques Delaunay, Thierry Guillaume, Thomas Gastinne, Beatrice Mahé, Viviane Dubruille, Nicolas Blin, Amandine Le Bourgeois, Éolia Brissot, Laurence Lodé, Steven Le Gouill, Philippe Moreau, Mohamad Mohty, Patrice Chevallier	10
8	Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center 2014 ·Annals of Oncology ·Marion Loirat, Patrice Chevallier, Christophe Leux, Philippe Moreau, Céline Bossard, Thierry Guillaume, Thomas Gastinne, J. Delaunay, Nicolas Blin, Beatrice Mahé, Viviane Dubruille, Karine Augeul-Meunier, Pierre Péterlin, Hervé Maisonneuve, Nadine Juge‐Morineau, Henry Jardel, Mohamad Mohty, Steven Le Gouill	30
9	Early detection of acute graft‐versus‐host disease by wireless capsule endoscopy and probe‐based confocal laser endomicroscopy: results of a pilot study 2014 ·United European Gastroenterology Journal ·Emmanuel Coron, Valérie Laurent, Florent Malard, Marc Le Rhun, Patrice Chevallier, Thierry Guillaume, Jean‐François Mosnier, Jean–Paul Galmiche, Mohamad Mohty	13
10	Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial 2014 ·Haematologica ·Didier Blaise, (unknown), (unknown), Jean‐Marie Boher, Agnès Boyer-Chammard, Reza Tabrizi, (unknown), Nathalie Fegueux, Anne Sîrvent, Mauricette Michallet, Jacques Olivier Bay, (unknown), Jean El Cheikh, Laure Vincent, Thierry Guillaume, Caroline Régny, Nöel Milpied, Luca Castagna, Mohamad Mohty	18
11	Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults 2014 ·Experimental Hematology ·Amandine Le Bourgeois, Myriam Labopin, Thierry Guillaume, Jacques Delaunay, Yohann Foucher, Benoît Tessoulin, Florent Malard, Sameh Ayari, Pierre Péterlin, Sophie Derenne, (unknown), Anne Cesbron, Katia Gagne, Laurence Lodé, (unknown), Berthe‐Marie Imbert‐Marcille, Steven Le Gouill, Philippe Moreau, Mohamad Mohty, Patrice Chevallier	11
12	Prospective Comparison Of Five Viral Infections (HHV6, CMV, EBV, ADV, BKv) After Umbilical Cord Blood (UCB) Vs PBSC Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation (allo-SCT) In Adults 2013 ·Blood ·Berthe‐Marie Imbert‐Marcille, Lucie Planche, Marie Rimbert, Claire Le Houérou, Céline Bressollette‐Bodin, Thierry Guillaume, Amandine Le Bourgeois, Jacques Delaunay, Philippe Moreau, Mohamad Mohty, Patrice Chevallier	1
13	Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study 2012 ·Blood ·Patrice Chevallier, Nelly Robillard, Aude Charbonnier, Emmanuel Raffoux, Sébastien Maury, Sylvain Carras, Cécile Moluçon‐Chabrot, Cécile Fohrer, Marc Bernard, (unknown), Anne Etienne, Pascaline Talmant, Jacques Delaunay, Thierry Guillaume, Mohamad Mohty, Marie C. Béné, Norbert Ifrah, Hervé Dombret	11
14	Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation 2011 ·Leukemia ·Zinaida Perić, Xavier Cahu, Patrice Chevallier, Éolia Brissot, Florent Malard, Thierry Guillaume, J. Delaunay, Sameh Ayari, Viviane Dubruille, Steven Le Gouill, Beatrice Mahé, Thomas Gastinne, Nicolas Blin, (unknown), (unknown), Philippe Moreau, Nöel Milpied, Marianne Coste‐Burel, (unknown), Mohamad Mohty	57
15	Re-administration of a combination of chemotherapy+Gemtuzumab at relapse in CD33+ AML patient allows to second remission and is feasible without extra toxicity 2007 ·Leukemia Research ·Patrice Chevallier, Cyrille Touzeau, Sameh Ayari, Thierry Guillaume, Jean‐Luc Harousseau, Jacques Delaunay	2
16	Autologous peripheral blood stem cell transplantation for lung cancer 1999 ·Best Practice & Research Clinical Haematology ·Thierry Guillaume, Daniel B. Rubinstein, Ken S. Zaner, Yves Humblet, Michel Symann	4
17	Retroviral-mediated gene transfer of human multidrug resistance associated murine hematopoietic cells 1998 ·British Journal of Haematology ·Jean‐Pascal Machiels, Véronique D’Hondt, Anne-Sophie Govaerts, Thierry Guillaume, (unknown), (unknown), Alexander Bank, Michel Symann	1
18	Retroviral-mediated gene transfer of murine IL-12 into tumor cells and fibroblasts as a strategy to increase the host anti-tumor immune system 1996 ·Cancer Gene Therapy ·(unknown), Marc André, Thierry Guillaume, (unknown), (unknown), Michel Symann	1
19	Tolerance and Effectiveness of Combined Il-3 and G-csf in Collecting Peripheral-blood Progenitor Cells (pbpc) Following Disease-oriented Chemotherapy 1993 ·Experimental Hematology ·Véronique D’Hondt, Yves Humblet, Thierry Guillaume, Chantal Doyen, Jean‐Claude Osselaer, Benjamin B. Mull, Michel Symann	1
20	Restriction fragment length polymorphisms and single germline coding region sequence in VH182, a duplicated gene encoding autoantibody 1993 ·Molecular Immunology ·Daniel B. Rubinstein, Michel Symann, A. Keith Stewart, Thierry Guillaume	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact